Efficacy of the traditional medication for treatment of the Hepatitis B (sirupe Hebovera) which support the production of antibody against surface antigen Hepatitis B (anti HBs) in the chronic HBsAg carriers

S.Hebevera (extract from traditional medicinal plants for treating chronic HBsAg carriers, its effect on sero- conversion from HBs(-) to anti HBs(+). The authors used S. Hebevera (S.H) for treating 72 chronic HBsAg carriers, observed that after two months of therapy, 45 patients (62,50%) had anti HBs(-) converted to anti HBs(+). Determination of anti HBs concentration recorded the average value of 201,77 IU/I (range 7,6 - 5046); 62,22% reached values of anti HBs between 11-100 IU/I. Particularly, Siro Hebevera denoted long-lasting activities. Moreover, Siro Hebevera proved well tolerated, no unwanted side-effects (allergy, intolerance); some advantages are noted such as appetite, weight gain